Trial
NCT01424345
The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
CAMC Health System
Collaborators
—
Condition
Kidney Transplant Immunosuppression
Intervention
adjustment of immunosuppressant dosages
Why stopped
The PI is relocating to another State/ another hospital
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-20